» Authors » Colin I Johnston

Colin I Johnston

Explore the profile of Colin I Johnston including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 29
Citations 2112
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Bernardi S, Toffoli B, Zennaro C, Tikellis C, Monticone S, Losurdo P, et al.
Nephrol Dial Transplant . 2011 Nov; 27(5):1793-800. PMID: 22036945
Background: Angiotensin II (AngII) contributes to salt-driven kidney damage. In this study, we aimed at investigating whether and how the renal damage associated with a high-salt diet could result from...
12.
Carrington M, Retegan C, Johnston C, Jennings G, Stewart S
J Clin Nurs . 2008 Dec; 18(5):678-86. PMID: 19077020
Aims And Objectives: Community awareness of the importance of hypercholesterolemia and the need for appropriate therapy is an important part of global efforts to reduce the population burden of cardiovascular...
13.
Nelson M, Reid C, Ames D, Beilin L, Donnan G, Gibbs P, et al.
Med J Aust . 2008 Jul; 189(2):105-9. PMID: 18637782
Aim: To determine the feasibility of performing a large clinical trial of the use of aspirin for the primary prevention of cardiovascular disease in older participants--the ASPirin in Reducing Events...
14.
Dart A, Kingwell B, Gatzka C, Willson K, Liang Y, Berry K, et al.
Hypertension . 2008 Feb; 51(4):1129-34. PMID: 18259023
This study examined the importance of aortic dimensions in determining pulse pressure in elderly hypertensives participating in the 2nd Australian National Blood Pressure Study, including a substantial number not previously...
15.
Dart A, Cameron J, Gatzka C, Willson K, Liang Y, Berry K, et al.
Hypertension . 2007 May; 49(6):1242-7. PMID: 17470723
The Second Australian National Blood Pressure Trial reported better prognosis for hypertensive subjects randomly assigned to an angiotensin-converting enzyme inhibitor (ACE-I) compared with a diuretic-based regimen despite no difference in...
16.
Dart A, Gatzka C, Kingwell B, Willson K, Cameron J, Liang Y, et al.
Hypertension . 2006 Mar; 47(4):785-90. PMID: 16505196
Central arterial waveforms and related indices of large artery properties can be determined with relative ease. This would make them an attractive adjunct in the risk stratification for cardiovascular disease....
17.
Jandeleit-Dahm K, Lassila M, Davis B, Candido R, Johnston C, Allen T, et al.
J Hypertens . 2005 Oct; 23(11):2071-82. PMID: 16208151
Objective: To investigate the effects of the combined angiotensin-converting enzyme (ACE)/neutral endopeptidase (NEP) inhibitor omapatrilat on atherosclerosis and renal injury in a model of diabetes-associated accelerated atherosclerosis and renal injury....
18.
Reid C, Ryan P, Miles H, Willson K, Beilin L, Brown M, et al.
Blood Press . 2005 Jul; 14(3):133-8. PMID: 16036492
The characterization of blood pressure in treatment trials assessing the benefits of blood pressure lowering regimens is a critical factor for the appropriate interpretation of study results. With numerous operators...
19.
Nelson M, Ryan P, Willson K, Reid C, Beilin L, Jennings G, et al.
Am J Hypertens . 2005 Jun; 18(6):885-8. PMID: 15925752
Background: The identification of factors that contribute to noncompliance with trial drug initiation where virtually complete compliance might be expected, may help identify patients whose management is least likely to...
20.
Jandeleit-Dahm K, Tikellis C, Reid C, Johnston C, Cooper M
J Hypertens . 2005 Feb; 23(3):463-73. PMID: 15716683
Recent trials have suggested that inhibitors of the renin-angiotensin system (RAS), such as angiotensin-converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARBs), may reduce the incidence of new-onset diabetes...